stress urinary incontinence

French medical device manufacturer UroMems completes €23M in Series B funding

By Sara Mageit 04:44 am April 8, 2021

Grenoble-based developer and manufacturer of the electronic artificial urinary sphincter (eAUS), UroMems has raised an additional €7 million in the second round of its Series B financing which was completed in May 2020. The additional investment was provided by existing investors including Hil-Invent GmbH, Financière Arbevel, Wellington Partners, Bpifrance, via its FABS fund, Supernova Invest and...

FDA authorizes digital Ebola test for emergency use, data on Omada's diabetes prevention program, and more digital health news briefs

By Dave Muoio 04:19 pm November 14, 2018

De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...